询盘
消息
吉林亚泰制药股份有限公司

吉林亚泰制药股份有限公司

China - Changchun
制造商
主营产品
植物提取物,制药,草本药物,补益药品,呼吸系统用药
产品目录
吉林亚泰制药股份有限公司
  • 吉林亚泰制药股份有限公司
  • 吉林亚泰制药股份有限公司
  • 吉林亚泰制药股份有限公司
  • 吉林亚泰制药股份有限公司
企业信息
Jilin Yatai Pharmaceutical Co., LTD. Was founded in 1999,It is a joint venture between Jilin Yatai Group and Dalian Tianfu Technology,Engaged in modern Chinese medicine research and development, production, sales as one of the high-tech enterprises.Total assets of 538 million yuan.With annual sales of over 300 million yuan, it is an independent innovative high-tech enterprise engaged in the research, development, production and sales of modern Traditional Chinese medicine,For "Jilin Province high-tech enterprise", "Jilin Province small giant enterprise".Company's main production, sales, with independent intellectual property rights of national class I Chinese medicine monomer anti-cancer drugs--Ginseng saponin Rg3 and its preparations "ShenYi capsule".Shenyi capsule is China's first oral targeted anti-tumor drug after artemisinin,The main ingredients of ginseng saponin Rg3 content in ginseng at three over one hundred thousand,Industrial production technology has become a world problem,Our company has realized the industrial production of 95% Rg3 for the first time,So that Rg3 capsules participate in the creation of a leading level of technology.In 2014, Shenyi Capsule, a class I Chinese medicinal monomer, won the second prize of National Scientific and Technological Invention in 2013.In 2017, it was included in the national medical insurance directory as one of the first negotiated varieties.In 2016, the enterprise invested more than 100 million yuan in the class I monomer Traditional Chinese medicine forsythiin project,CFDA approved it for phase I-III clinical study. Enterprise plant covers an area of 41846 square meters,It can produce tablets, capsules, granules and other dosage forms, and has passed the national GMP certification.Existing staff 300 people, after 18 years has created a high-quality, professional team.Adhering to the tenet of innovation, profit and wealth creation, the staff will fully open up the new era of Yatai Pharmaceuticals and make greater contributions to the country and society.
Jilin Yatai Pharmaceutical Co., LTD. Was founded in 1999,It is a joint venture between Jilin Yatai Group and Dalian Tianfu Technology,Engaged in modern Chinese medicine research and development, production, sales as one of the high-tech enterprises.Total assets of 538 million yuan.With annual sales of over 300 million yuan, it is an independent innovative high-tech enterprise engaged in the research, development, production and sales of modern Traditional Chinese medicine,For "Jilin Province high-tech enterprise", "Jilin Province small giant enterprise".Company's main production, sales, with independent intellectual property rights of national class I Chinese medicine monomer anti-cancer drugs--Ginseng saponin Rg3 and its preparations "ShenYi capsule".Shenyi capsule is China's first oral targeted anti-tumor drug after artemisinin,The main ingredients of ginseng saponin Rg3 content in ginseng at three over one hundred thousand,Industrial production technology has become a world problem,Our company has realized the industrial production of 95% Rg3 for the first time,So that Rg3 capsules participate in the creation of a leading level of technology.In 2014, Shenyi Capsule, a class I Chinese medicinal monomer, won the second prize of National Scientific and Technological Invention in 2013.In 2017, it was included in the national medical insurance directory as one of the first negotiated varieties.In 2016, the enterprise invested more than 100 million yuan in the class I monomer Traditional Chinese medicine forsythiin project,CFDA approved it for phase I-III clinical study. Enterprise plant covers an area of 41846 square meters,It can produce tablets, capsules, granules and other dosage forms, and has passed the national GMP certification.Existing staff 300 people, after 18 years has created a high-quality, professional team.Adhering to the tenet of innovation, profit and wealth creation, the staff will fully open up the new era of Yatai Pharmaceuticals and make greater contributions to the country and society.
年度总收入
前三市场
营业地点
Changchun,Jilin Province,China(Mainland)
Total Employees
201-300人
成立年份
1999
注册资金
RMB null
办公区
產品認證
GMP
贸易能力
出口百分比
最近的港口
接受的交付條款
雇员
201-300人
接受的付款貨幣
接受的付款方式
貿易署員工人數
平均提前期
null 天)
资质认证
  • 图片
  • Certification Name
  • 认证
  • 主营业务
  • 有效时间
GMP
China
管理体系证书
2019-03-25 ~ 2024-03-24
生产能力
工厂规模
工厂位置
合同起草(名词
年产值
品管人员数量
研发人员人数
联系我们
相关公司